Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis

被引：0
作者：
Désirée M van der Heijde
Dennis A Revicki
Katherine L Gooch
Robert L Wong
Hartmut Kupper
Neesha Harnam
Chris Thompson
Joachim Sieper
机构：
[1] Leiden University Medical Center,Department of Rheumatology
[2] Leiden,Center for Health Outcomes Research
[3] United BioSource Corporation,Global Health Economics and Outcomes Research
[4] Abbott Laboratories,Formerly Abbott Immunology
[5] Abbott Laboratories,Medical Department I, Rheumatology, Charité
[6] Abbott GmbH & Co. KG,undefined
[7] Campus Benjamin Franklin,undefined
[8] and German Rheumatism Research Center,undefined
来源：
Arthritis Research & Therapy | / 11卷
关键词：
Ankylose Spondylitis; Adalimumab; Physical Component Summary; Mental Component Summary; Minimum Clinically Important Difference;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 297 条
[1]  
Gran JT(1993)The epidemiology of ankylosing spondylitis Semin Arthritis Rheum 22 319-334
[2]  
Husby G(2004)Health status of patients with ankylosing spondylitis: a comparison with the general population Ann Rheum Dis 63 1605-1610
[3]  
Dagfinrud H(2003)Functional disability and quality of life in patients with ankylosing spondylitis Rheumatol Int 23 121-126
[4]  
Mengshoel AM(2000)Disability and handicap in rheumatoid arthritis and ankylosing spondylitis: Results from the German rheumatological database J Rheumatol 27 613-622
[5]  
Hagan KB(1998)Quality of life in patients with ankylosing spondylitis Rheum Dis Clin North Am 24 815-827
[6]  
Loge JH(2003)Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis Ann Rheum Dis 62 20-26
[7]  
Kvien TK(2005)Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab Arthritis Res Ther 7 R439-R444
[8]  
Bostan EE(2007)How do the EQ-5D, SF-6D and the well-being rating scale compare in patients with ankylosing spondylitis? Ann Rheum Dis 66 771-777
[9]  
Borman P(2005)Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis Rheumatology (Oxford) 44 342-348
[10]  
Bodur H(2005)Persistent clinical response to the anti-TNF-alpha antibody infliximab in patients with ankylosing spondylitis over 3 years Rheumatology (Oxford) 44 670-676
12345678910